We are live on ! Find out more

ODDITY Tech

ODD

Market cap $1B

21.69 USD

+0.82

3.93%

At close Updated Oct 29, 4:00 PM EDT

Pre-market

After hours

21.31

-0.38

1.75%

1 day

3.93%

5 days

-5.78%

1 month

21.17%

3 months

44.89%

6 months

38.42%

Year to date

-45.02%

1 year

-53.53%

5 years

-54.37%

10 years

-54.37%

About: ODDITY Tech Ltd offers a consumer tech platform that is built to transform the beauty and wellness market. The ODDITY platform is designed to support a portfolio of brands and services that innovate and disrupt the expansive beauty and wellness market. It consumes user data to develop physical beauty and wellness products that deliver performance and functionality. Its brands include SpoiledChild and IL Makiage. Geographically, the company generates majority revenue from United states followed by other countries and Israel.

Employees: 658

Consumer Staples Household & Personal Products

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 64.3%

Neutral 35.7%

Negative 0%

Zacks Investment Research

New Strong Buy Stocks for October 29th

ODD, BOOM, BSRR, AIN and MUR have been added to the Zacks Rank #1 (Strong Buy) List on October 29th, 2026.

New Strong Buy Stocks for October 29th

ODDITY to Announce Third Quarter 2026 Financial Results on November 11, 2026

NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (NASDAQ: ODD) today announced that it will release its third quarter 2026 financial results before the market open on Wednesday, November 11, 2026, to be followed by a conference call at 8:30 a.m. Eastern Time.

ODDITY to Announce Third Quarter 2026 Financial Results on November 11, 2026

Zacks Investment Research

Oddity Tech (ODD) Upgraded to Strong Buy: Here's What You Should Know

Oddity Tech (ODD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Oddity Tech (ODD) Upgraded to Strong Buy: Here's What You Should Know

Zacks Investment Research

New Strong Buy Stocks for October 15th

KMX, ACIC, ONC, ODD and WES have been added to the Zacks Rank #1 (Strong Buy) List on October 15, 2026.

New Strong Buy Stocks for October 15th

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition

NANJING, China, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that opamtistomig (LBL-024), the Company's proprietary PD‑L1/4‑1BB bispecific antibody, has been granted Orphan Drug Designation (ODD) by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of extrapulmonary neuroendocrine carcinoma (EP-NEC). This is the third Orphan Drug Designation for opamtistomig, following designations in the U.S. Food and Drug Administration (FDA) and the European Commission (EC), marking a further expansion of its global regulatory recognition into a strategically important Asian market.

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition

Zacks Investment Research

Earnings Estimates Moving Higher for Oddity Tech (ODD): Time to Buy?

Oddity Tech (ODD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Earnings Estimates Moving Higher for Oddity Tech (ODD): Time to Buy?

Oddity Tech: Turnaround Potential And Discounted Debt Value Lever

ODD's turnaround could benefit from improving acquisition costs, even if profitability takes longer to recover than revenue. SpoiledChild is a nice, growing revenue base. And METHODIQ and Labs offer longer-term opportunities beyond IL MAKIAGE's potential recovery. ODD also has convertible bonds trading at a discount and a 0% coupon. This is essentially cheap debt that gives ODD flexibility and an interesting value lever.

Oddity Tech: Turnaround Potential And Discounted Debt Value Lever

The Motley Fool

Why Oddity Tech's Stock Skyrocketed 26.5% Today

Oddity Tech's second-quarter sales fell 25% to $181 million, just ahead of Wall Street's target. Earnings fell from $0.92 per share to $0.20, topping analyst estimates by a penny.

Why Oddity Tech's Stock Skyrocketed 26.5% Today

Oddity Tech Ltd. (ODD) Q2 2026 Earnings Call Transcript

Oddity Tech Ltd. (ODD) Q2 2026 Earnings Call Transcript

Oddity Tech Ltd. (ODD) Q2 2026 Earnings Call Transcript

Proactive Investors

ODDITY shares surge on Q2 beat and raised FY26 guidance

ODDITY (NASDAQ:ODD) shares jumped 14% on Thursday after the company posted second-quarter results that topped Wall Street estimates and issued a stronger-than-expected full-year profit outlook. The consumer tech company reported revenue of $181 million for the quarter, beating estimates of $178 million but down 25% from a year earlier.

ODDITY shares surge on Q2 beat and raised FY26 guidance

See News Rankings

Price charts implemented using Lightweight Charts™